About Us
Vission, Mission and Values
Our Team
Management
Advisors
Portfolio
Research & Development
Clinical Evidence
Natural Health Products
Partnerships
Manufacturing
Formulation
Clinical Trials
Research
Nutritional Supplements
Investors
Announcements
Presentations
Media
Contact Us
Media
Sign up to receive the latest announcements on Woke Pharmaceuticals....
Your Name
Your Email
Latest Media
04.08.22
Media
Potential Therapeutic Benefits of Psychedelics
Read More
11.07.22
Media
Can microdosing psychedelics improve your mental health? Here's what the science says
Read More
13.06.22
Media
Elon Musk has joined the celebrity support for psychedelics
Read More
10.06.22
Media
Woke and UWA enter agreement to identify novel LSD analogues
Read More
19.05.22
Media
Could psychedelic drugs be the key to treating mental health issues?
Read More
27.04.22
Media
Macquarie University media release regarding clinical trial with Woke
Read More
17.01.22
Media
CY2022 CEO Corporate Overview
Read More
ACN: 651 290 729
Address: Suite 301, 10 Bridge St, Sydney NSW 2000 Australia
Email:
info@wokeph.com
close
chevron-down
bars
